[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-364601-105":59,"doc-detail-364601-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","contract-to-kill-gnas-mutation-review","Contract to kill: GNAS mutation - review","","The mutation in Gsα-coding GNAS exons, known as the gsp oncogene, is identified as the most frequent mutation across oncogenesis-related heterotrimeric G proteins. Key variants, including GNAS R201 and Q227, occur across multiple neoplasms and cancers such as IPMN, pituitary, thyroid, appendiceal, and colorectal tumors. This review highlights how oncogenic GNAS drives tumor formation, progression, and maintenance, and surveys therapeutic strategies targeting Gsα as a neoantigen, using allele-specific inhibitors and cyclic peptide-based small molecules. Alternative treatment modalities and patient-centered approaches to reduce the impact of GNAS mutations are discussed, along with future research directions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/contract-to-kill-gnas-mutation-review/364601/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/contract-to-kill-gnas-mutation-review/364601.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is the GNAS mutation considered central in oncogenesis?","Question",{"text":112,"@type":113},"The review describes Gsα-coding GNAS exon mutations (gsp oncogene) as the most frequent across oncogenesis-involved heterotrimeric G proteins, with major variants like GNAS R201 and Q227 found in many cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which GNAS transcripts and isoforms are highlighted?",{"text":117,"@type":113},"The article outlines multiple transcripts produced from the complex locus, including Gsα, GNAS A/B, XLαs, NESPAS, and NESP55, with distinct N-terminals and different allele-specific methylation patterns.",{"name":119,"@type":110,"acceptedAnswer":120},"How does Gsα function at the molecular level according to the review?",{"text":121,"@type":113},"Gsα is described as having a Ras-like domain with GTPase activity and an α-helical domain; GPCR activation disrupts GDP-related interactions, destabilizes GDP binding, and promotes conformational changes that enhance GTP binding.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},364601,1790198159,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Raut etal. Molecular Cancer (2025) 24:70 [https://doi.org/10.1186/s12943-025-02247-4](https://doi.org/10.1186/s12943-025-02247-4)  \nMolecular Cancer  \n REVIEW Open Access  \nContract to kill: GNAS mutation  \nPratima Raut1, Poompozhil Mathivanan1, Surinder K. Batra 1,2* and Moorthy P. Ponnusamy 1,2*  \nAbstract  \nThe mutation in Gsα-coding GNAS exons, popular as gsp oncogene, is the most frequent mutation across all heterotrimeric G proteins involved in oncogenesis. GNAS R201, the most frequently mutated, followed by Q227, are found predominantly across various neoplasms and cancers such as IPMN, pituitary, thyroid, appendiceal, colorectal, etc.  \nThis review emphasizes the pivotal significance of the gsp oncogene and its ramifications underpinning the sustained addiction to GNAS mutation. Recent studies delineating the mechanistic intricacies that provide solid evidence of the profound impact of oncogenic GNAS on tumor formation, progression, and maintenance are highlighted. We have leveraged the discoveries of Gsα as an ideal neoantigen candidate for vaccine therapy, allele-specific inhibitors, and cyclic peptide-based small molecular inhibitors for G proteins and explored the therapeutic potential to target oncogenic GNAS directly. Alternative therapeutic modalities and patient-centric studies to mitigate the impact of GNAS mutations are also discussed. The exposition of novel studies and strategies designed to address the potential challenges inherent in these approaches of targeting the activating mutations of GNAS, along with probable avenues for further investigation, are highlighted. This review aims to reverberate the current understanding of the oncogenic potential of GNAS, the genomic and biological landscape of GNAS-driven neoplasms and cancers, and potential therapeutic strategies against them.  \nKeywords GNAS, Gsα, GNAS R201, Mutation, Tumor, Neoplasm  \nIntroduction: structural and functional attributes of GNAS  \nGNAS (guanine nucleotide alpha-stimulating binding protein) is an imprinted gene with the complex locus on the q arm of chromosome 20 [1]. It incorporates four alternative promoters, and its first exon splices onto exon two and encodes multiple transcripts: Gsα (Gs-α long), GNAS A/B (Gs-α short), XLαs (extra-long α s), NESPAS, and NESP55 with exons 2–13 in common [1, 2] (Fig. 1). The three transcripts, Gsα, GNAS A/B, and XLαs, are isoforms with distinct N-terminals [3]. The  \n*Correspondence: Surinder K. Batra[sbatra@unmc.edu](sbatra@unmc.edu)[ ](sbatra@unmc.edu)Moorthy P. Ponnusamy [mpalanim@unmc.edu](mpalanim@unmc.edu)  \n1 Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA  \n2 Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA  \nsecond overlapping open reading frame of XL exon 1 encodes another product, ALEX (alternative gene product encoded by XL exon). NESP55 is very distinct from Gsα as it has a stop codon in its first exon, and thus, the entire coding region is located within the first exon itself. The expression of these transcripts is biallelic, paternal, or maternal based on the allele-specific methylation of their promoters on differentially demethylated regions [4] (Fig. 1). Gsα is not methylated and has biallelic expression, with silenced paternal expression in some tissues. NESP55 is methylated in the paternal allele and maternally expressed along with Gsα. Transcripts such as GNAS A/B, XLαs, and NESPAS are expressed in the paternal allele as these are methylated in the maternal allele [4].  \nDelving into the biochemical structure, Gsα, the major product of GNAS, comprises a Ras-like domain, which possesses GTPase activity, and the α-helical domain [5]. The nucleotide-binding pocket is located between these two domains and is surrounded by P-loop and switch  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0","cbCaiiKRxTfVM4Jf","https://ap.wps.com/l/cbCaiiKRxTfVM4Jf","pdf",2308805,12,"English","# Introduction: structural and functional attributes of GNAS\n## Transcript organization and imprinting\n## Biochemical structure and signaling mechanism","[{\"question\":\"Why is the GNAS mutation considered central in oncogenesis?\",\"answer\":\"The review describes Gsα-coding GNAS exon mutations (gsp oncogene) as the most frequent across oncogenesis-involved heterotrimeric G proteins, with major variants like GNAS R201 and Q227 found in many cancers.\"},{\"question\":\"Which GNAS transcripts and isoforms are highlighted?\",\"answer\":\"The article outlines multiple transcripts produced from the complex locus, including Gsα, GNAS A/B, XLαs, NESPAS, and NESP55, with distinct N-terminals and different allele-specific methylation patterns.\"},{\"question\":\"How does Gsα function at the molecular level according to the review?\",\"answer\":\"Gsα is described as having a Ras-like domain with GTPase activity and an α-helical domain; GPCR activation disrupts GDP-related interactions, destabilizes GDP binding, and promotes conformational changes that enhance GTP binding.\"}]","Contract to kill: GNAS mutation - review | PDF",1790158505,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/020a1ebac05810b167cfc318f78cc889.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1f82d525ad0ad1328d58db10ca4195b2.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/285fd1bd143c0ff10c2210e6993d1f35.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7155ce931235bbc9f751edef482604a.webp",980,1301]